Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia. - Wikidata - awgldk - TriplyDB

Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia.

Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia.

http://www.wikidata.org/entity/Q42360054

about

From selection hits to clinical leads: progress in aptamer discovery Nucleic Acid aptamers: new methods for selection, stabilization, and application in biomedical science Modulation of the Coagulation Cascade Using Aptamers Biology of tissue factor pathway inhibitor.Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass.Novel therapeutic approaches for haemophilia.Aptamer BAX 499 mediates inhibition of tissue factor pathway inhibitor via interaction with multiple domains of the protein.2017 Clinical trials update: Innovations in hemophilia therapy.Novel therapies and current clinical progress in hemophilia A.Effects of an acidic environment on coagulation dynamics.The Potential Close Future of Hemophilia Treatment - Gene Therapy, TFPI Inhibition, Antithrombin Silencing, and Mimicking Factor VIII with an Engineered Antibody.Identification of serpins specific for activated protein C using a lysate-based screening assay.

P2860

Q26752799-03486308-D68D-44B5-B12B-9C6402B7EC49 Q26995510-F1E1F743-3B0D-410F-A414-7FB0E8C3E531 Q28816936-DAA0E2D5-8DE7-4839-B606-8F7F9F9C6694 Q33585249-70A0F84F-ACE7-4957-A33F-78F5E4804BA3 Q36956166-18261D23-4CA1-4F8D-A65C-75AB4998954C Q38293116-63EC0602-6232-4F21-A2D5-94D6D1FB2E70 Q38316749-69E26EBA-17B7-46BE-A5C5-CB4B9D71A113 Q38937725-19EDC11A-F648-4756-BE4A-A059D7B7D21B Q49745450-868F5DC4-92AA-4744-A3A6-07B831063B4F Q51633018-AF6EADB7-3F52-4273-9668-66F7DEF536B8 Q55211396-4CDF88AC-7E39-4E54-88D6-D93DCCF750A4 Q55261637-B9221521-6B8C-4F16-B66C-4E6D4FAE59E3

P2860

Effect of BAX499 aptamer on tissue factor pathway inhibitor function and thrombin generation in models of hemophilia.

http://www.wikidata.org/entity/Q42360054

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Effect of BAX499 aptamer on ti ...... ation in models of hemophilia.

@en

Effect of BAX499 aptamer on ti ...... ation in models of hemophilia.

@nl

type

label

Effect of BAX499 aptamer on ti ...... ation in models of hemophilia.

@en

Effect of BAX499 aptamer on ti ...... ation in models of hemophilia.

@nl

prefLabel

Effect of BAX499 aptamer on ti ...... ation in models of hemophilia.

@en

Effect of BAX499 aptamer on ti ...... ation in models of hemophilia.

@nl

P1433

Q42360054-582FEFF5-5475-4487-A976-0D4144417D4E

P1476

Q42360054-379A4FEC-27D6-4211-85EC-F5EB7E299699

P2093

Q42360054-23DD7B6B-8357-4ADE-84C9-C8969DD09F56

Q42360054-6B4E0ACB-A5EC-4DC1-A2E3-8D5221729F1A

Q42360054-8DD9B9F8-4F4A-4B35-80A6-E09DEA5CC155

Q42360054-9A5D39DC-2C03-41B0-98DD-971323F6522D

P2860

Q42360054-09FD432B-9811-4D7C-9FDB-35D204111ACA

Q42360054-13731295-CED6-4ED6-A487-D28FC704483E

Q42360054-13D5C967-1FD7-424F-BCD3-9D1CE9E76014

Q42360054-19F53A08-FDA5-4A26-BB6F-78414D211D6B

Q42360054-1A01D120-FC90-404C-ADA1-57AE0FBE5CBC

Q42360054-221F38F1-7F19-4E20-9ED8-191304DC099A

Q42360054-22C60628-0CB9-46B4-9D16-FBB9EE383632

Q42360054-26EC45FC-8104-4755-A78A-FF435927F4F7

Q42360054-2F48B764-9E06-4030-9774-9D0016B625CD

Q42360054-393D139B-6A70-4E9C-9D17-8CC5197C50C4

P304

Q42360054-361F65D7-D428-461B-88AB-9B5D42344E20

P31

Q42360054-D3E15064-464D-491F-8D96-737103A9B10D

P356

Q42360054-D4E3B570-68BC-4611-BD1E-8325B50A15DE

P433

Q42360054-DF7A6C49-08B2-47BC-A5E4-F0EFFBCB11B8

P478

Q42360054-6B332181-B212-48F1-8124-E69748F515F0

P577

Q42360054-1F025CC3-BA8C-46D1-8E68-156511EC3A96

P698

Q42360054-D618EE8C-9003-45EC-BB22-1C3B9EC7F7E8

P921

Q42360054-34018007-23EF-4EA9-A85C-9A9A00CC1B06

P932

Q42360054-AD6385E8-A2BA-4343-9F1B-FF1C6726E0C2

P356

J.THROMRES.2012.08.299

P1433

Thrombosis Research

P1476

Effect of BAX499 aptamer on ti ...... ation in models of hemophilia.

@en

P2093

Jonathan H Foley

http://www.w3.org/2001/XMLSchema#string

Matthew Gissel

http://www.w3.org/2001/XMLSchema#string

Saulius Butenas

http://www.w3.org/2001/XMLSchema#string

Thomas Orfeo

http://www.w3.org/2001/XMLSchema#string

P2860

Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma

Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiation.

A simple method for the preparation of homogeneous phospholipid vesicles.

Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis

Haemophilias A and B.

Recombinant factor VIIa analog NN1731 (V158D/E296V/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma.

Isolation of functional human coagulation factor V by using a hybridoma antibody

Solulin increases clot stability in whole blood from humans and dogs with hemophilia.

Discordant fibrin formation in hemophilia.

Inhibitor development in haemophilia B: an orphan disease in need of attention.

P304

948-955

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.THROMRES.2012.08.299

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

130

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22951415

http://www.w3.org/2001/XMLSchema#string

P921

P932

3508133

http://www.w3.org/2001/XMLSchema#string